Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis
Background/purpose: The aim of this study was to systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes. Methods: Included were all COVID-19 published studies between January 1 to July 20, 2020. The random effect mod...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664620306033 |
id |
doaj-bb83a99a604a4ad0aebefd4bd8a83c87 |
---|---|
record_format |
Article |
spelling |
doaj-bb83a99a604a4ad0aebefd4bd8a83c872021-08-22T04:28:13ZengElsevierJournal of the Formosan Medical Association0929-66462021-09-01120917061718Clinical and laboratory findings of COVID-19: A systematic review and meta-analysisAmar Hassan Khamis0Mohamed Jaber1Aida Azar2Feras AlQahtani3Khaled Bishawi4Ahmed Shanably5Biostatistics, Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, P.O Box 505055, Dubai UAE, Building 14, Dubai Healthcare City, United Arab EmiratesClinical Sciences Department, College of Dentistry, Ajman University, P.O Box 346, Ajman, Ajman, United Arab Emirates; Corresponding author. Clinical Sciences Department Ajman University, College of Dentistry Ajman, P.O Box 346, United Arab Emirates.Epidemiology, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, P.O Box 505055, Dubai UAE, Building 14, Dubai Healthcare City, United Arab EmiratesCollege of Dentistry, Ajman University, United Arab Emirates, P.O Box 346, Ajman, Ajman, United Arab EmiratesCollege of Dentistry, Ajman University, United Arab Emirates, P.O Box 346, Ajman, Ajman, United Arab EmiratesCollege of Dentistry, Ajman University, United Arab Emirates, P.O Box 346, Ajman, Ajman, United Arab EmiratesBackground/purpose: The aim of this study was to systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes. Methods: Included were all COVID-19 published studies between January 1 to July 20, 2020. The random effect model was used to calculate the pooled prevalence and corresponding 95% confidence interval (CI). Publication bias was assessed using the funnel plot for the standard error by logit event. Results: The mean age of the patients was 46.8 years (95% CI, 41.0–52.6) and males comprised 54.0% (95% CI, 51.3–56.7). Total co-morbidities prevalence was 29.5% (95% CI, 19.0–36.6), with diabetes mellitus being the most prevalent 13.8% (95% CI, 8.7–21.1), followed by hypertension 11.7% (95% CI, 5.7–22.6), and cardiovascular disease 9.7% (95% CI, 6.5–14.2). The most common clinical manifestations were fever, 82.0% (95% CI, 67.7–90.8), cough 54.3% (95% CI, 45.5–62.9), fatigue 30.2% (95% CI, 23.3–38.1), sputum 28.5% (95% CI, 21.2–37.2), sore throat 21.7% (95% CI, 14.6–31.0), and headache 11.0% (95% CI, 7.9–15.2). The most common COVID-19 serious complications were RNA Anemia 98.2% (95% CI, 96.2–99.2), hospitalization 83.7% (95% CI, 76.0–89.3), bilateral pneumonia 70.9% (95% CI, 58.2–81.0); of those hospitalized 43.5% (95% CI, 24.9–64.2) were discharged. Fatality accounted for 10.5% (95% CI 6.8–16.1). Conclusion: Patients infected with COVID-19 coronavirus showed a wide range of clinical presentation with non-specific symptoms.http://www.sciencedirect.com/science/article/pii/S0929664620306033COVID-19SARS-CoV-2Clinical featuresEpidemicMeta-analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amar Hassan Khamis Mohamed Jaber Aida Azar Feras AlQahtani Khaled Bishawi Ahmed Shanably |
spellingShingle |
Amar Hassan Khamis Mohamed Jaber Aida Azar Feras AlQahtani Khaled Bishawi Ahmed Shanably Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis Journal of the Formosan Medical Association COVID-19 SARS-CoV-2 Clinical features Epidemic Meta-analysis |
author_facet |
Amar Hassan Khamis Mohamed Jaber Aida Azar Feras AlQahtani Khaled Bishawi Ahmed Shanably |
author_sort |
Amar Hassan Khamis |
title |
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis |
title_short |
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis |
title_full |
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis |
title_fullStr |
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis |
title_full_unstemmed |
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis |
title_sort |
clinical and laboratory findings of covid-19: a systematic review and meta-analysis |
publisher |
Elsevier |
series |
Journal of the Formosan Medical Association |
issn |
0929-6646 |
publishDate |
2021-09-01 |
description |
Background/purpose: The aim of this study was to systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes. Methods: Included were all COVID-19 published studies between January 1 to July 20, 2020. The random effect model was used to calculate the pooled prevalence and corresponding 95% confidence interval (CI). Publication bias was assessed using the funnel plot for the standard error by logit event. Results: The mean age of the patients was 46.8 years (95% CI, 41.0–52.6) and males comprised 54.0% (95% CI, 51.3–56.7). Total co-morbidities prevalence was 29.5% (95% CI, 19.0–36.6), with diabetes mellitus being the most prevalent 13.8% (95% CI, 8.7–21.1), followed by hypertension 11.7% (95% CI, 5.7–22.6), and cardiovascular disease 9.7% (95% CI, 6.5–14.2). The most common clinical manifestations were fever, 82.0% (95% CI, 67.7–90.8), cough 54.3% (95% CI, 45.5–62.9), fatigue 30.2% (95% CI, 23.3–38.1), sputum 28.5% (95% CI, 21.2–37.2), sore throat 21.7% (95% CI, 14.6–31.0), and headache 11.0% (95% CI, 7.9–15.2). The most common COVID-19 serious complications were RNA Anemia 98.2% (95% CI, 96.2–99.2), hospitalization 83.7% (95% CI, 76.0–89.3), bilateral pneumonia 70.9% (95% CI, 58.2–81.0); of those hospitalized 43.5% (95% CI, 24.9–64.2) were discharged. Fatality accounted for 10.5% (95% CI 6.8–16.1). Conclusion: Patients infected with COVID-19 coronavirus showed a wide range of clinical presentation with non-specific symptoms. |
topic |
COVID-19 SARS-CoV-2 Clinical features Epidemic Meta-analysis |
url |
http://www.sciencedirect.com/science/article/pii/S0929664620306033 |
work_keys_str_mv |
AT amarhassankhamis clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis AT mohamedjaber clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis AT aidaazar clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis AT ferasalqahtani clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis AT khaledbishawi clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis AT ahmedshanably clinicalandlaboratoryfindingsofcovid19asystematicreviewandmetaanalysis |
_version_ |
1721200339945783296 |